BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33322097)

  • 1. Assessment of the Relationship between Mortality and Troponin I Levels in Hospitalized Patients with the Novel Coronavirus (COVID-19).
    Özyılmaz S; Ergün Alış E; Ermiş E; Allahverdiyev S; Uçar H
    Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33322097
    [No Abstract]   [Full Text] [Related]  

  • 2. Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID-19: Derivation and Validation of the HA
    Manocha KK; Kirzner J; Ying X; Yeo I; Peltzer B; Ang B; Li HA; Lerman BB; Safford MM; Goyal P; Cheung JW
    J Am Heart Assoc; 2021 Mar; 10(6):e018477. PubMed ID: 33121304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study.
    Lombardi CM; Carubelli V; Iorio A; Inciardi RM; Bellasi A; Canale C; Camporotondo R; Catagnano F; Dalla Vecchia LA; Giovinazzo S; Maccagni G; Mapelli M; Margonato D; Monzo L; Nuzzi V; Oriecuia C; Peveri G; Pozzi A; Provenzale G; Sarullo F; Tomasoni D; Ameri P; Gnecchi M; Leonardi S; Merlo M; Agostoni P; Carugo S; Danzi GB; Guazzi M; La Rovere MT; Mortara A; Piepoli M; Porto I; Sinagra G; Volterrani M; Specchia C; Metra M; Senni M
    JAMA Cardiol; 2020 Nov; 5(11):1274-1280. PubMed ID: 32845276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Elevated Troponin to Predict Death in Patients With COVID-19 and Myocardial Injury.
    Majure DT; Gruberg L; Saba SG; Kvasnovsky C; Hirsch JS; Jauhar R;
    Am J Cardiol; 2021 Jan; 138():100-106. PubMed ID: 33058800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis.
    Malik P; Patel U; Patel NH; Somi S; Singh J
    Infez Med; 2020 Dec; 28(4):500-506. PubMed ID: 33257623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cardiac troponin I and mortality in patients with COVID-19.
    Salvatici M; Barbieri B; Cioffi SMG; Morenghi E; Leone FP; Maura F; Moriello G; Sandri MT
    Biomarkers; 2020 Dec; 25(8):634-640. PubMed ID: 33003961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19.
    He X; Wang L; Wang H; Xie Y; Yu Y; Sun J; Yan J; Du Y; Shen Y; Zeng H
    Sci Rep; 2020 Nov; 10(1):20452. PubMed ID: 33235220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced cardiac function is associated with cardiac injury and mortality risk in hospitalized COVID-19 Patients.
    Chen LQ; Burdowski J; Marfatia R; Weber J; Gliganic K; Diaz N; Ramjattan N; Zheng H; Mihalatos D; Wang L; Barasch E; Leung A; Gopal A; Craft J; Ren X; Stergiopoulos K; Jeremias A; Petrossian G; Robinson N; Levine J; Shlofmitz RA; Gulotta RJ; Muehlbauer SM; Lucore CL; Cao JJ
    Clin Cardiol; 2020 Dec; 43(12):1547-1554. PubMed ID: 33280140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Elevated Cardiac Troponin I in Hospitalized Covid-19 Patients.
    Shah P; Doshi R; Chenna A; Owens R; Cobb A; Ivey H; Newton S; Mccarley K
    Am J Cardiol; 2020 Nov; 135():150-153. PubMed ID: 32861733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study).
    Iorio A; Lombardi CM; Specchia C; Merlo M; Nuzzi V; Ferraro I; Peveri G; Oriecuia C; Pozzi A; Inciardi RM; Carubelli V; Bellasi A; Canale C; Camporotondo R; Catagnano F; Dalla Vecchia L; Giovinazzo S; Maccagni G; Mapelli M; Margonato D; Monzo L; Provenzale G; Sarullo F; Tomasoni D; Ameri P; Gnecchi M; Leonardi S; Agostoni P; Carugo S; Danzi GB; Guazzi M; La Rovere MT; Mortara A; Piepoli M; Porto I; Volterrani M; Sinagra G; Senni M; Metra M
    Am J Cardiol; 2022 Mar; 167():125-132. PubMed ID: 35063263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin.
    Kaufmann CC; Ahmed A; Kassem M; Freynhofer MK; Jäger B; Aicher G; Equiluz-Bruck S; Spiel AO; Vafai-Tabrizi F; Gschwantler M; Fasching P; Wojta J; Giannitsis E; Huber K
    Clin Res Cardiol; 2022 Mar; 111(3):343-354. PubMed ID: 34782921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?
    Tahir Huyut M; Huyut Z; İlkbahar F; Mertoğlu C
    Int Immunopharmacol; 2022 Apr; 105():108542. PubMed ID: 35063753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan.
    Pya Y; Bekbossynova M; Gaipov A; Lesbekov T; Kapyshev T; Kuanyshbek A; Tauekelova A; Litvinova L; Sailybayeva A; Vakhrushev I; Sarria-Santamera A
    PLoS One; 2021; 16(12):e0261272. PubMed ID: 34936681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Injury and Outcomes of Patients With COVID-19 in New York City.
    Maeda T; Obata R; Rizk D; Kuno T
    Heart Lung Circ; 2021 Jun; 30(6):848-853. PubMed ID: 33279410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Inflammatory Markers with Mortality in COVID-19 Infection.
    Arshad AR; Khan I; Shahzad K; Arshad M; Haider SJ; Aslam MJ
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):158-163. PubMed ID: 33291195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
    Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
    Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts.
    Castro VM; McCoy TH; Perlis RH
    JAMA Netw Open; 2020 Oct; 3(10):e2023934. PubMed ID: 33125498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Troponin I Is an Independent Predictor for Mortality in Hospitalized Patients With COVID-19.
    Nie SF; Yu M; Xie T; Yang F; Wang HB; Wang ZH; Li M; Gao XL; Lv BJ; Wang SJ; Zhang XB; He SL; Qiu ZH; Liao YH; Zhou ZH; Cheng X
    Circulation; 2020 Aug; 142(6):608-610. PubMed ID: 32539541
    [No Abstract]   [Full Text] [Related]  

  • 19. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19.
    Stefanini GG; Chiarito M; Ferrante G; Cannata F; Azzolini E; Viggiani G; De Marco A; Briani M; Bocciolone M; Bragato R; Corrada E; Gasparini GL; Marconi M; Monti L; Pagnotta PA; Panico C; Pini D; Regazzoli D; My I; Kallikourdis M; Ciccarelli M; Badalamenti S; Aghemo A; Reimers B; Condorelli G;
    Heart; 2020 Oct; 106(19):1512-1518. PubMed ID: 32817312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of daily troponin I and D-dimer serum levels on mortality in COVID-19 pneumonia patients.
    Stavileci B; Ereren E; Özdemir E; Özdemir B; Cengiz M; Enar R
    Cardiovasc J Afr; 2023 Jan-Apr 23; 34(1):16-22. PubMed ID: 35687085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.